A372320 Share Price Performance
₩55,200.00
25500.00 (85.86%)
Price ₩55,200.00
Share Pricen/a
Is Curocell (KOSDAQ:372320) Using Too Much Debt?
Jan 05
Curocell Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
A372320 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Curocell Inc. Key Details
About A372320
- Founded
- 2016
- Employees
- 136
- CEO
- WebsiteView website
Curocell Inc. develops CAR-T cell therapy for the treatment of cancer. It focuses on the development of CD19 CAR-T for the treatment of lymphoma; and BCMA CAR-T for the treatment of multiple myeloma. The company was incorporated in 2016 and is based in Daejeon, South Korea.
